Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 018709
Company: APOTHECON
Company: APOTHECON
| Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
|---|---|---|---|---|---|---|---|
| CAPOZIDE 25/15 | CAPTOPRIL; HYDROCHLOROTHIAZIDE | 25MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL | Discontinued | None | Yes | No |
| CAPOZIDE 25/25 | CAPTOPRIL; HYDROCHLOROTHIAZIDE | 25MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL | Discontinued | None | Yes | No |
| CAPOZIDE 50/15 | CAPTOPRIL; HYDROCHLOROTHIAZIDE | 50MG;15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL | Discontinued | None | Yes | No |
| CAPOZIDE 50/25 | CAPTOPRIL; HYDROCHLOROTHIAZIDE | 50MG;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | TABLET;ORAL | Discontinued | None | Yes | No |